As Filed With the Securities and Exchange Commission on January 11, 2008
                                                     Registration No. 333-139886
================================================================================

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                   POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


                              CAVIT SCIENCES, INC.
             (Exact name of registrant as specified in its charter)

       FLORIDA                                              03-0586935
(State of Incorporation)                    (I.R.S. Employer Identification No.)

          100 East Linton Boulevard, Suite 106B, Delray Beach, FL 85260
               (Address of Principal Executive Offices) (Zip Code)


     Cavit Sciences, Inc. 2006 Employee and Consultant Stock Incentive Plan
                            (Full title of the plan)

                                  Colm J. King
                                President and CEO
                        100 East Linton Blvd., Suite 106B
                             Delray Beach, FL 33483
                     (Name and address of agent for service)

                                 (561) 278-7856
          (Telephone number, including area code, of agent for service)

                                   Copies to:

                               David E. Wise, Esq.
                            8794 Rolling Acres Trail
                          Fair Oaks Ranch, Texas 78015
                                 (830) 981-8165

================================================================================

             DEREGISTRATION OF COMMON STOCK - EXPLANATORY STATEMENT

     On  January  10,  2007,  Cavit  Sciences,   Inc.,  a  Florida   corporation
("Company"),  filed  with the  Securities  and  Exchange  Commission  ("SEC")  a
registration   statement  on  Form  S-8,  File  No.  333-139886   ("Registration
Statement") in order to register 2,000,000 shares of the Company's common stock,
par value $.01 per share ("Common Stock").

     This Post-Effective  Amendment No. 1 to the Registration Statement is being
filed  pursuant  to  Item  512(a)(3)  of  regulation  S-B  for  the  purpose  of
deregistering  1,632,107  shares of Common Stock  originally  registered  on the
Registration   Statement  with  respect  to  the  Company's  2006  Employee  and
Consultant Stock Incentive Plan ("2006 Plan").  The Company is deregistering the
remaining  shares of Common Stock issuable under the 2006 Plan because there are
no  outstanding  stock  options  under the 2006 Plan.  Accordingly,  the Company
hereby  withdraws  from  registration  under  the  Registration   Statement  the
1,632,107 shares that have not been and will not be issued under the 2006 Plan.

                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this registration
statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the city of Delray  Beach,  Florida on this 11th day of January,
2008.

                                       CAVIT SCIENCES, INC.


                                       By: /s/ Colm J. King
                                           -------------------------------------
                                           Colm J. King
                                           President and Chief executive Officer

     Pursuant to the  requirements  of the  Securities  Act of 1933, as amended,
this  registration  statement  has been signed by the  following  persons in the
capacities indicated as of January 11, 2008.

     Signatures                                        Title
     ----------                                        -----


/s/  Colm J. King                President, Chief Executive Officer and Director
- ---------------------------
Colm J. King


/s/ Julio De Leon                Chief Financial Officer, Secretary and Director
- ---------------------------
Julio De Leon


/s/ Raymond S. Bazley            Director
- ---------------------------
Raymond S. Bazley